Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has provided an update.
Wai Chun Bio-Technology Ltd. has announced its non-compliance with the board diversity requirement under Rule 13.92 of the Hong Kong Stock Exchange Listing Rules, as it currently has a single-gender board. The company is actively seeking to appoint a qualified female independent non-executive director (INED) by the second quarter of 2025 to meet the diversity standards. Despite challenges such as a limited talent pool and stringent qualification requirements, the company is committed to achieving a balanced and diverse board composition.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. is a company incorporated in the Cayman Islands, primarily operating in the biotechnology sector. The company focuses on developing and providing biotechnological solutions and products, with a market emphasis on innovation and diversity in its operations.
Average Trading Volume: 229,924
Technical Sentiment Signal: Hold
Current Market Cap: HK$24.63M
Find detailed analytics on 0660 stock on TipRanks’ Stock Analysis page.